BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26621952)

  • 41. Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life.
    Deltas C; Savva I; Voskarides K; Papazachariou L; Pierides A
    Nephron; 2015; 130(4):271-80. PubMed ID: 26201269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by
    Matthaiou A; Poulli T; Deltas C
    Clin Kidney J; 2020 Dec; 13(6):1025-1036. PubMed ID: 33391746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome.
    Buzza M; Wilson D; Savige J
    Kidney Int; 2001 May; 59(5):1670-6. PubMed ID: 11318937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alport Syndrome: Achieving Early Diagnosis and Treatment.
    Kashtan CE
    Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Familial hematuria due to type IV collagen mutations: Alport syndrome and thin basement membrane nephropathy.
    Kashtan CE
    Curr Opin Pediatr; 2004 Apr; 16(2):177-81. PubMed ID: 15021198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial haematuria due to thin basement membrane nephropathy.
    Bailey RR
    N Z Med J; 1990 Jul; 103(893):312-3. PubMed ID: 2371004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
    Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
    Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
    Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
    Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathological Features of Hereditary Nephritis in the Iranian Population: Analysis of a 14-Year Survey in Kidney Biopsies From a Large Referral Center.
    Emami A; Nili F; Sotoudeh Anvari M; Salarvand S; Seirafi G
    Arch Iran Med; 2024 Jan; 27(1):8-14. PubMed ID: 38431955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and diagnostic utility of genomic sequencing for children referred to a Kidney Genomics Clinic with microscopic haematuria.
    Shanks J; Butler G; Cheng D; Jayasinghe K; Quinlan C
    Pediatr Nephrol; 2023 Aug; 38(8):2623-2630. PubMed ID: 36715773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel model of autosomal dominant Alport syndrome in Dalmatian dogs.
    Hood JC; Huxtable C; Naito I; Smith C; Sinclair R; Savige J
    Nephrol Dial Transplant; 2002 Dec; 17(12):2094-8. PubMed ID: 12454218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal histological features of school-age children with asymptomatic haematuria and/or proteinuria: a multicenter study.
    Zhai Y; Xu H; Shen Q; Cao Q; Zhu G; Wei M; Sun L; Liu H; Rao J; Fang X; Chen J; Guo W
    Nephrology (Carlton); 2014 Jul; 19(7):426-31. PubMed ID: 24720478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. De novo X-linked Alport syndrome in a 3-year-old girl.
    Komatsu H; Goda T; Nozu K
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31308192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Approach to Persistent Microscopic Hematuria in Children.
    Kallash M; Rheault MN
    Kidney360; 2020 Sep; 1(9):1014-1020. PubMed ID: 35369549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical features of thin basement membrane nephropathy.
    Gregory MC
    Semin Nephrol; 2005 May; 25(3):140-5. PubMed ID: 15880323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants.
    Liapis H; Gökden N; Hmiel P; Miner JH
    Hum Pathol; 2002 Aug; 33(8):836-45. PubMed ID: 12203217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy.
    Savige J; Gregory M; Gross O; Kashtan C; Ding J; Flinter F
    J Am Soc Nephrol; 2013 Feb; 24(3):364-75. PubMed ID: 23349312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Collagen IV (alpha3-alpha4) nephropathy].
    Torra R; Tazón B; Ars E; Ballarín J
    Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coexistence of thin membrane and alport nephropathies in families with haematuria.
    Moghal NE; Milford DV; White RH; Raafat F; Higgins R
    Pediatr Nephrol; 1999 Nov; 13(9):778-81. PubMed ID: 10603120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.